Biosimilars 2015

Interact with FDA and international agencies to discuss the latest updates and outlooks for biosimilar regulation, while examining the potential implications for patients and HCPs.

会议日程

天 1 2015 年 10 月 18 日

1:30 PM — 5:00 PM

Tutorial: Achieving Biosimilarity Through Matching of Critical Quality Attributes to Reference Products

天 2 2015 年 10 月 19 日

7:30 AM — 8:30 AM

8:30 AM — 9:00 AM

9:00 AM — 10:45 AM

Session 1: Biosimilars in the US & Europe

10:45 AM — 11:15 AM

11:15 AM — 12:30 PM

Session 2: Quality Considerations - Part One

12:30 PM — 1:45 PM

1:45 PM — 3:00 PM

3:00 PM — 3:30 PM

3:30 PM — 4:45 PM

Session 3: Clinical and Pharmacology Considerations

4:45 PM — 5:45 PM

天 3 2015 年 10 月 20 日

7:30 AM — 8:30 AM

8:30 AM — 10:00 AM

Session 4: Unique Features of Developing Biosimilars in Oncology

10:00 AM — 10:15 AM

10:15 AM — 12:15 PM

12:15 PM — 1:15 PM

1:15 PM — 2:45 PM

Session 6: Pushing Well Forward - Commercialization of Biosimilars Post-2020

2:45 PM — 4:15 PM

Session 7: Interchangeability

4:15 PM — 4:30 PM

4:30 PM — 4:30 PM

Biosimilars 2015

会议日程

获得信息并保持参与